Just read a analyst report that suggests EPT is talking to large companies in regards to commercialisation and a possible deal. They are assuming a 10% royalty which would probably come along with a placement to the relative company + up front payment. The market size is very large (billions if they can make a cream but even hundreds of millions using the current proven method).
Given Phase II release in in a few weeks and that the market cap is under 30m it just seems too good to be true??
Any ideas??
Thanks,
Munch
epitan - commercialisation contract
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.98 |
Change
-0.120(0.79%) |
Mkt cap ! $750.1M | |||
| Open | High | Low | Value | Volume |
| $15.02 | $15.13 | $14.85 | $364.4K | 24.32K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 374 | $14.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.00 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |